JOHNSON & JOHNSON
An institutional investment manager in NEW BRUNSWICK, NJ. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 6, 2026. SEC CIK 200406.
- Reported value$798.7m
- Positions15
Holdings: 15 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 300 | 37.6% | 2,449,183 | Unchanged | |
| NanobiotixNBTX | SPONSORED ADS | 63009J107 | 212 | 26.5% | 5,623,816 | Unchanged | |
| Meiragtx Holdings plc | COM | G59665102 | 89.7 | 11.2% | 6,641,064 | Unchanged | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 74.4 | 9.3% | 1,784,517 | Unchanged | |
| Contineum Therapeutics IncCTNM | CL A | 21217B100 | 32.4 | 4.1% | 1,979,173 | Unchanged | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 23.5 | 2.9% | 814,586 | Unchanged | |
| CVRX IncCVRX | COM | 126638105 | 20.7 | 2.6% | 4,024,861 | Unchanged | |
| Xencor IncXNCR | COM | 98401F105 | 12.0 | 1.5% | 748,062 | Unchanged | |
| Cerebras Systems IncCBRS | COM CL A | 15675D103 | 11.8 | 1.5% | 53,586 | New+53,586 | |
| Fate Therapeutics IncFATE | COM | 31189P102 | 9.1 | 1.1% | 3,379,064 | Unchanged | |
| Procept Biorobotics CorpPRCT | COM | 74276L105 | 8.1 | 1.0% | 357,939 | Unchanged | |
| Neumora Therapeutics Inc.NMRA | COM | 640979100 | 3.1 | 0.4% | 1,849,445 | Unchanged | |
| VOR Biopharma IncVOR | COM NEW | 929033207 | 1.0 | 0.1% | 53,732 | Unchanged | |
| Standard Biotools IncLAB | COM | 34385P108 | 0.3 | <0.1% | 311,967 | Unchanged | |
| Adicet Bio IncACET | COM NEW | 007002207 | 0.2 | <0.1% | 22,779 | Unchanged |
Sold out: 2 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Nano-X Imaging Ltd. | ORD SHS | M70700105 | 0.0 | 0.0% | 0 | Sold out−83,554 | |
| Rallybio CorporationRLYB | COM | 75120L209 | 0.0 | 0.0% | 0 | Sold out−152,901 |
Source: SEC EDGAR, Form 13F-HR, accession 0000904454-26-000435 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.